PGEN
Precigen Inc
NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY
$4.16
+0.97% today
Updated 2026-04-30
Market cap
$1.46B
P/E ratio
—
P/S ratio
150.58x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$1 – $5
Volume
4.6M
Precigen Inc (PGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-474.60%
ROE
-572.00%
ROA
-44.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $8.01M | $-85.28M | 100.00% | -1,028.67% | -1,064.27% |
| 2012 | $13.93M | $-81.87M | -359.85% | -539.73% | -587.96% |
| 2013 | $23.76M | $-38.98M | -102.71% | -244.20% | -164.06% |
| 2014 | $71.93M | $-81.82M | 73.22% | -97.26% | -113.75% |
| 2015 | $173.60M | $-84.49M | 63.18% | -84.60% | -48.67% |
| 2016 | $190.93M | $-186.61M | 67.72% | -65.56% | -97.74% |
| 2017 | $230.98M | $-117.02M | 72.82% | -59.70% | -50.66% |
| 2018 | $160.57M | $-509.34M | 60.59% | -314.88% | -317.20% |
| 2019 | $31.99M | $-170.52M | 83.20% | -269.81% | -533.01% |
| 2020 | $31.99M | $-170.52M | -40.04% | -269.81% | -533.01% |
| 2021 | $14.27M | $-92.17M | -276.24% | -644.48% | -646.01% |
| 2022 | $26.91M | $28.32M | 76.44% | -281.42% | 105.23% |
| 2023 | $6.22M | $-95.90M | 1.70% | -1,602.54% | -1,540.63% |
| 2024 | $3.92M | $-126.23M | -8.71% | -3,440.23% | -3,216.18% |
| 2025 | $9.68M | $-250.64M | 37.05% | -1,100.78% | -2,588.21% |